These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29149279)

  • 1. Impact of Isolating Clostridium difficile Carriers on the Burden of Isolation Precautions: A Time Series Analysis.
    Xiao Y; Paquet-Bolduc B; Garenc C; Gervais P; Trottier S; Roussy JF; Longtin J; Loo VG; Longtin Y
    Clin Infect Dis; 2018 Apr; 66(9):1377-1382. PubMed ID: 29149279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.
    Meltzer E; Smollan G; Huppert A; Fluss R; Tal I; Gilboa M; Zilberman-Daniels T; Keller N; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2019 Sep; 25(9):1127-1132. PubMed ID: 30771530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.
    Grigoras CA; Zervou FN; Zacharioudakis IM; Siettos CI; Mylonakis E
    PLoS One; 2016; 11(6):e0156577. PubMed ID: 27258068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and Isolation of Clostridium difficile Asymptomatic Carriers During Clostridium difficile Infection Outbreaks: An Exploratory Study.
    Paquet-Bolduc B; Gervais P; Roussy JF; Trottier S; Oughton M; Brukner I; Longtin J; Loo VG; Dascal A; Longtin Y
    Clin Infect Dis; 2018 Nov; 67(11):1781-1783. PubMed ID: 29771298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection incidence: impact of audit and feedback programme to improve room cleaning.
    Smith A; Taggart LR; Lebovic G; Zeynalova N; Khan A; Muller MP
    J Hosp Infect; 2016 Feb; 92(2):161-6. PubMed ID: 26679727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.
    Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA
    J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
    Guerrero DM; Becker JC; Eckstein EC; Kundrapu S; Deshpande A; Sethi AK; Donskey CJ
    J Hosp Infect; 2013 Oct; 85(2):155-8. PubMed ID: 23954113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents.
    Donskey CJ; Sunkesula VCK; Stone ND; Gould CV; McDonald LC; Samore M; Mayer J; Pacheco SM; Jencson AL; Sambol SP; Petrella LA; Gulvik CA; Gerding DN
    Infect Control Hosp Epidemiol; 2018 Aug; 39(8):909-916. PubMed ID: 29848392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in Clostridium difficile infection rates following a multifacility prevention initiative in Orange County, California: A controlled interrupted time series evaluation.
    Rizzo KR; Yi SH; Garcia EP; Zahn M; Epson E
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):872-879. PubMed ID: 31124428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
    Price J; Cheek E; Lippett S; Cubbon M; Gerding DN; Sambol SP; Citron DM; Llewelyn M
    Clin Microbiol Infect; 2010 Aug; 16(8):1297-302. PubMed ID: 19832710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of Clostridium difficile colonization.
    Hung YP; Lee JC; Lin HJ; Liu HC; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Jun; 48(3):241-8. PubMed ID: 24890755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between bed occupancy rates and Clostridium difficile infections: a time-series analysis.
    Kaier K; Luft D; Dettenkofer M; Kist M; Frank U
    Epidemiol Infect; 2011 Mar; 139(3):482-5. PubMed ID: 20513253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.
    Abbett SK; Yokoe DS; Lipsitz SR; Bader AM; Berry WR; Tamplin EM; Gawande AA
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1062-9. PubMed ID: 19751156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
    Forster AJ; Daneman N; van Walraven C
    J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
    Longtin Y; Trottier S; Brochu G; Paquet-Bolduc B; Garenc C; Loungnarath V; Beaulieu C; Goulet D; Longtin J
    Clin Infect Dis; 2013 Jan; 56(1):67-73. PubMed ID: 23011147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.
    Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A
    Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.